MUFG Securities EMEA’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Sell
34,556
-181,222
-84% -$12.1M 0.02% 301
2026
Q1
$13.6M Buy
215,778
+199,789
+1,250% +$13.9M 0.2% 81
2025
Q4
$1.06M Buy
15,989
+8,483
+113% +$548K 0.01% 398
2025
Q3
$505K Buy
7,506
+6,355
+552% +$503K 0.01% 362
2025
Q2
$100K Buy
+1,151
New +$90.2K ﹤0.01% 316
2023
Q1
Sell
-44,000
Closed -$4.98M 132
2022
Q4
$4.98M Buy
+44,000
New +$4.83M 0.08% 68
2019
Q2
Sell
-2,334,000
Closed -$69.5M 419
2019
Q1
$69.5M Buy
+2,334,000
New +$82M 0.8% 20

Other funds holding DXCM

MUFG Securities EMEA's DXCM Position: Q2 2026 in Review

MUFG Securities EMEA reduced its DexCom (DXCM) stake by 84% in Q2 2026, selling an estimated $12.1M and leaving 34,556 shares worth $2.33M. The position accounts for 0.02% of the portfolio, ranked #301.

MUFG Securities EMEA first reported a position in DXCM in Q1 2019 and has held it in 7 quarters since. The position peaked at $69.5M in Q1 2019. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MUFG Securities EMEA held 34,556 shares of DexCom worth $2.33M as of Q2 2026.
  • MUFG Securities EMEA sold 181,222 DexCom shares in Q2 2026, an estimated $12.1M.
  • DexCom made up 0.02% of MUFG Securities EMEA's portfolio in Q2 2026, its #301 holding.
  • MUFG Securities EMEA first reported a position in DexCom in Q1 2019 and has held it in 7 quarters since.
  • MUFG Securities EMEA's DexCom position peaked at $69.5M in Q1 2019.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.